Israel’s Check-Cap has announced positive results from its latest US pilot study of its C-Scan colon capsule system. The dual-center study achieved both primary (safety) and secondary (patient satisfaction and performance) endpoints. C-Scan is already CE approved. http://ir.check-cap.com/2019-12-30-Check-Cap-Announces-Positive-Results-from-U-S-Pilot-Study-of-C-Scan-R-System

Following on from good Phase 2 trials (see here) Israel’s Sol-Gel reported excellent results from pivotal Phase 3 clinical trials of its Twyneo treatment of patients with acne vulgaris. The trial significantly reduced moderate-to-severe acne in 858 patients aged nine … Continue reading →

Israeli-founded Emendo Biotherapeutics, based in New York, utilizes protein engineering for precision gene editing, to treat certain genetic disorders and diseases. It has seven treatments in early stages of development. Emendo has just raised $61 million of funding. https://www.calcalistech.com/ctech/articles/0,7340,L-3777874,00.html https://emendobio.com/

Scientists at Israel’s Ben Gurion University and Weizmann Institute have discovered how shrimp can see in the murky depths of the sea. The biocrystal coating of their retina light detectors may inspire the development of new optical coatings and specialized … Continue reading →

As reported previously (see here), Israel’s Nanox has developed technology to lower the cost of X-ray imaging and make it more accessible to the developing world. Nanox has just received $26 million funding for its Nanox.Arc digital X-ray device and … Continue reading →